SHIKIAR ASSET MANAGEMENT INC - MADRIGAL PHARMACEUTICALS INC ownership

MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 207 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.

Quarter-by-quarter ownership
SHIKIAR ASSET MANAGEMENT INC ownership history of MADRIGAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$730
-51.4%
5,000
-23.1%
0.25%
-47.5%
Q2 2023$1,501
-4.7%
6,5000.0%0.48%
-13.6%
Q1 2023$1,575
-99.6%
6,5000.0%0.56%
+229.4%
Q3 2022$422,000
-9.2%
6,5000.0%0.17%
-5.0%
Q2 2022$465,000
-52.6%
6,500
-35.0%
0.18%
-35.6%
Q1 2022$981,000
+5.3%
10,000
-9.1%
0.28%
+17.3%
Q4 2021$932,000
-6.5%
11,000
-12.0%
0.24%
-15.7%
Q3 2021$997,000
-26.9%
12,500
-10.7%
0.28%
-27.0%
Q2 2021$1,364,000
+6.0%
14,000
+27.3%
0.38%
-11.5%
Q1 2021$1,287,000
-3.5%
11,000
-8.3%
0.44%
-9.4%
Q4 2020$1,334,000
-6.4%
12,0000.0%0.48%
-12.2%
Q3 2020$1,425,000
+4.9%
12,0000.0%0.55%
-11.6%
Q2 2020$1,359,000
+69.7%
12,0000.0%0.62%
+15.1%
Q1 2020$801,000
-49.5%
12,000
-31.0%
0.54%
+2.5%
Q4 2019$1,585,000
+12.5%
17,400
+6.5%
0.52%
-5.7%
Q3 2019$1,409,000
-12.4%
16,341
+6.5%
0.56%
-11.4%
Q2 2019$1,608,000
-16.3%
15,3410.0%0.63%
-21.9%
Q1 2019$1,922,000
+18.9%
15,341
+7.0%
0.80%
-4.7%
Q4 2018$1,617,000
-50.8%
14,341
-6.5%
0.84%
-33.9%
Q3 2018$3,285,000
-33.0%
15,341
-12.5%
1.28%
-37.7%
Q2 2018$4,906,000
+90.6%
17,541
-20.4%
2.05%
+75.2%
Q1 2018$2,574,000
+21.2%
22,041
-4.8%
1.17%
+17.9%
Q4 2017$2,124,000
+104.0%
23,1410.0%0.99%
+119.9%
Q3 2017$1,041,000
+323.2%
23,141
+52.8%
0.45%
+326.4%
Q2 2017$246,00015,1410.11%
Other shareholders
MADRIGAL PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Tao Capital Management LP 77,657$11,3428.78%
University of Wisconsin Foundation 40,133$5,861,0236.72%
Paulson & Co. 500,000$73,020,0006.53%
TCG Crossover Management, LLC 179,917$26,275,0793.87%
Avoro Capital Advisors LLC 1,555,000$227,092,2003.54%
Affinity Asset Advisors, LLC 85,000$12,413,4003.49%
Ghost Tree Capital, LLC 57,500$8,397,3002.76%
Lynwood Capital Management Inc. 5,000$730,2001.92%
MPM BioImpact LLC 40,859$5,967,0481.59%
Tri Locum Partners LP 33,761$4,930,4561.58%
View complete list of MADRIGAL PHARMACEUTICALS INC shareholders